2017
DOI: 10.1111/jmwh.12647
|View full text |Cite
|
Sign up to set email alerts
|

Consensus Bundle on Severe Hypertension During Pregnancy and the Postpartum Period

Abstract: Complications arising from hypertensive disorders of pregnancy are among the leading causes of preventable severe maternal morbidity and mortality. Timely and appropriate treatment has the potential to significantly reduce hypertension-related complications. To assist health care providers in achieving this goal, this patient safety bundle provides guidance to coordinate and standardize the care provided to women with severe hypertension during pregnancy and the postpartum period. This is one of several patien… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
36
0
15

Year Published

2018
2018
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 38 publications
(51 citation statements)
references
References 31 publications
0
36
0
15
Order By: Relevance
“…Similarly, guidelines from the multidisciplinary working group of the National Partnership for Maternal Safety has advised not using magnesium sulphate for the sole anti-hypertensive purpose, and so we excluded it in this review. [75] This is the first network meta-analysis in this field. The estimates generated from the present model will be useful to practitioners as it may take several years to conduct head-to-head clinical trials comparing several drugs for treating severe hypertension in pregnancy.…”
Section: Discussionmentioning
confidence: 97%
“…Similarly, guidelines from the multidisciplinary working group of the National Partnership for Maternal Safety has advised not using magnesium sulphate for the sole anti-hypertensive purpose, and so we excluded it in this review. [75] This is the first network meta-analysis in this field. The estimates generated from the present model will be useful to practitioners as it may take several years to conduct head-to-head clinical trials comparing several drugs for treating severe hypertension in pregnancy.…”
Section: Discussionmentioning
confidence: 97%
“…Ancak, zamanında ve uygun tedavi ile hipertansiyona bağlı istenmeyen durumlar önemli ölçüde azaltılabilir. 1,2 Hipertansiyon; gebelik döneminde kronik hipertansiyon, gestasyonel hipertansiyon, kökeninde kronik hipertansiyonun yer aldığı preeklampsi/eklampsi ve gebeliğin tetiklediği hipertansiyon (preeklampsi/eklampsi) olarak sınıflandırılmaktadır. 3 Kronik hipertansiyon, gebeliğin 20. haftasından önce kan basıncının yüksek olması (sistolik kan basıncı ≥140 mmHg ve/veya diyastolik kan basıncı ≥90 mmHg) veya doğumdan sonra 12 haftadan daha uzun süre devam etmesidir.…”
Section: Gebelik Ve Doğum Sonu Dönemdeunclassified
“…Preeklampsi patofizyolojisinin anlaşılmasına yönelik son gelişmeler, bu durumun önlenmesi, taranması ve yönetimi için yeni yollar açmıştır. 2,6 Bu çalışmada, güncel literatür ışığında gebelik ve postpartum dönemde şiddetli hipertansiyona ilişkin yeni uygulama ve yaklaşımlar konusunda sağlık hizmeti verenleri bilgilendirmek amacıyla yazılmıştır.…”
Section: Gebelik Ve Doğum Sonu Dönemdeunclassified
“…Im Rahmen dieser Maßnahmen beispielhaft hervorzuheben ist die Etablierung einer "National Partnership for Maternal Safety", einem Zusammenschluss von mehr als 30 Gesundheitsorganisationen, mit dem Ziel, durch Entwicklung und Verbreitung von einfachen, Evidenz-basierten Diagnose-und Handlungsschemata (keine Leitlinien) mit strukturierten Prozessabläufen ("Safety Bundles") die mütterliche Mortalität und Morbidität in den USA innerhalb von 5 Jahren um 50 % zu senken [16]. Zu den häufigsten Ursachen der Müttersterblichkeit in den USA -Blutungen, Hypertonie und Thromboembolien -wurden inzwischen derartige "Safety Bundles" publiziert [17][18][19].…”
Section: Einleitung Und Epidemiologieunclassified